New partnership boosts children's research at CMFT
Children's research at the NIHR / Wellcome Trust
Manchester Clinical Research Facility boosted through new
partnership with PPD.
Central Manchester University Hospitals NHS Foundation Trust
(CMFT) has formalised its relationship with Pharmaceutical Product
Development, LLC (PPD), with the clinical research facility
becoming part of an international paediatric investigator network
and affirming its commitment to paediatric research.
Through the network, CMFT aims to attract additional paediatric
studies and provide participation in research as a treatment option
for more children with rare diseases. The benefits of taking
part in research for patients and their families can include a
better understanding of their condition, and improved health
outcomes for them and/or future patients.
NIHR / Wellcome Trust Manchester Clinical Research Facility
(CRF) at the Royal Manchester Children's Hospital was the first
specialist facility in the North West and one of only a small
handful across the UK. The CRF, which also operates an
adult's facility on Grafton Street, offers state-of-the-art
equipment and facilities and has a team of specialist research
nurses and support staff.
Helen Pidd, Operations Director at the CRF said, "Many patients
cared for by our children's CRF suffer from complex health
conditions, for which there are no treatments currently
available. This is an exciting opportunity to provide further
opportunities for these patients to receive cutting edge
The paediatric investigator network-which includes seven other
world-renowned centres of excellence among its members-will also
provide biopharmaceutical companies with faster trial start up,
more predictable patient enrolment and higher-quality data.
Read PPD's press release.